» Articles » PMID: 34941261

Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2021 Dec 23
PMID 34941261
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Akt is a Ser/Thr protein kinase that regulates cell growth and metabolism and is considered a therapeutic target for cancer. Regulation of Akt by membrane recruitment and post-translational modifications (PTMs) has been extensively studied. The most well-established mechanism for cellular Akt activation involves phosphorylation on its activation loop on Thr308 by PDK1 and on its C-terminal tail on Ser473 by mTORC2. In addition, dual phosphorylation on Ser477 and Thr479 has been shown to activate Akt. Other C-terminal tail PTMs have been identified, but their functional impacts have not been well-characterized. Here, we investigate the regulatory effects of phosphorylation of Tyr474 and O-GlcNAcylation of Ser473 on Akt. We use expressed protein ligation as a tool to produce semisynthetic Akt proteins containing phosphoTyr474 and O-GlcNAcSer473 to dissect the enzymatic functions of these PTMs. We find that O-GlcNAcylation at Ser473 and phosphorylation at Tyr474 can also partially increase Akt's kinase activity toward both peptide and protein substrates. Additionally, we performed kinase assays employing human protein microarrays to investigate global substrate specificity of Akt, comparing phosphorylated versus O-GlcNAcylated Ser473 forms. We observed a high similarity in the protein substrates phosphorylated by phosphoSer473 Akt and O-GlcNAcSer473 Akt. Two Akt substrates identified using microarrays, PPM1H, a protein phosphatase, and NEDD4L, an E3 ubiquitin ligase, were validated in solution-phase assays and cell transfection experiments.

Citing Articles

The post-translational modification O-GlcNAc is a sensor and regulator of metabolism.

Morales M, Pratt M Open Biol. 2024; 14(10):240209.

PMID: 39474868 PMC: 11523104. DOI: 10.1098/rsob.240209.


Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation.

Fehsel K Biomedicines. 2024; 12(10).

PMID: 39457607 PMC: 11505606. DOI: 10.3390/biomedicines12102294.


Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy.

Hurtado-Carneiro V, LeBaut-Ayuso Y, Velazquez E, Flores-Lamas C, Fernandez-de la Rosa R, Garcia-Garcia L Heliyon. 2024; 10(15):e35752.

PMID: 39170185 PMC: 11337050. DOI: 10.1016/j.heliyon.2024.e35752.


Engineered reactivity of a bacterial E1-like enzyme enables ATP-driven modification of protein C termini.

Frazier C, Deb D, Weeks A bioRxiv. 2024; .

PMID: 38798401 PMC: 11118369. DOI: 10.1101/2024.05.13.593989.


Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism.

Li X, Hu S, Cai Y, Liu X, Luo J, Wu T Front Physiol. 2024; 14:1320964.

PMID: 38264327 PMC: 10804622. DOI: 10.3389/fphys.2023.1320964.


References
1.
Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings B . Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol. 2007; 5(4):e95. PMC: 1845162. DOI: 10.1371/journal.pbio.0050095. View

2.
Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C . The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 2008; 27(14):1932-43. PMC: 2486276. DOI: 10.1038/emboj.2008.120. View

3.
Brognard J, Sierecki E, Gao T, Newton A . PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell. 2007; 25(6):917-31. DOI: 10.1016/j.molcel.2007.02.017. View

4.
Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D . Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature. 2014; 508(7497):541-5. PMC: 4076493. DOI: 10.1038/nature13079. View

5.
Bolduc D, Rahdar M, Tu-Sekine B, Sivakumaren S, Raben D, Amzel L . Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. Elife. 2013; 2:e00691. PMC: 3707082. DOI: 10.7554/eLife.00691. View